Skip to main content
    I

    Instil Bio Inc. (TIL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.75
    -0.33 (-5.43%)

    Market Cap: $41.23M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Instil Bio Inc. (TIL) Earnings: Report Dates and Results

    Updated Aug 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Instil Bio (TIL) is expected to report earnings on Mar 25, 2027. In the quarter ended Jun 30, 2026, Instil Bio reported EPS of -$0.63, below the -$0.35 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    32%(7/22)
    Avg Surprise
    -4.53%

    Upcoming Estimates

    Reports Mar 25, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.04
    Range-$0.04 - -$0.04
    2 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    TIL has an expected report date of Mar 25, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, TIL beat 7 and missed 15. The widest gap in the table came in the quarter ended Jun 30, 2026, when EPS landed 80.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jun 30, 2026-$0.63-$0.35-$0.35 - -$0.35-80.00%MissN/A11 up, 0 downAug 13, 2026
    Mar 31, 2026-$0.62-$0.59-$0.62 - -$0.56-5.08%MissN/A21 up, 0 downMay 15, 2026
    Dec 31, 2025-$0.97-$3.78-$3.78 - -$3.78+74.34%BeatN/A11 up, 0 downMar 27, 2026
    Sep 30, 2025-$2.01-$2.35N/A+14.47%BeatN/A11 up, 0 downNov 13, 2025
    Jun 30, 2025-$2.88-$2.44-$2.44 - -$2.44-18.03%MissN/A11 up, 0 downAug 13, 2025
    Mar 31, 2025-$4.32-$2.59N/A-66.80%MissN/A11 up, 0 downMay 13, 2025
    Dec 31, 2024-$1.08-$3.65-$3.65 - -$3.65+70.41%BeatN/A10 up, 1 downMar 4, 2025
    Sep 30, 2024-$2.55-$3.08-$3.08 - -$1.08+17.21%BeatN/A40 up, 0 downNov 13, 2024
    Jun 30, 2024-$1.57-$3.04-$3.04 - -$2.92+48.36%BeatN/A20 up, 0 downAug 13, 2024
    Mar 31, 2024-$3.74-$2.23-$2.30 - -$2.16-67.71%MissN/A20 up, 0 downMay 10, 2024
    Dec 31, 2023-$1.26-$3.40-$3.40 - -$2.29+62.94%BeatN/A20 up, 0 downMar 21, 2024
    Sep 30, 2023-$3.20-$3.00-$3.00 - -$1.20-6.67%MissN/A40 up, 0 downNov 13, 2023
    Jun 30, 2023-$2.20-$2.00-$5.20 - -$2.00-10.00%MissN/A30 up, 0 downAug 14, 2023
    Mar 31, 2023-$5.00-$3.20-$3.20 - -$3.00-56.25%MissN/A20 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.24-$0.41-$0.42 - -$0.40+41.46%BeatN/A30 up, 0 downMar 27, 2023
    Sep 30, 2022-$8.60-$8.20-$9.40 - -$8.00-4.88%MissN/A50 up, 0 downNov 14, 2022
    Jun 30, 2022-$9.20-$8.27-$8.80 - -$7.60-11.25%MissN/A50 up, 0 downAug 12, 2022
    Mar 31, 2022-$8.40-$6.50N/A-29.23%MissN/A30 up, 0 downMay 16, 2022
    Dec 31, 2021-$0.43-$0.36-$0.39 - -$0.32-19.44%MissN/A4N/AMar 7, 2022
    Sep 30, 2021-$6.60-$6.13N/A-7.67%MissN/A5N/ANov 15, 2021
    Jun 30, 2021-$5.40-$4.00-$4.40 - -$4.00-35.00%MissN/A4N/AAug 12, 2021
    Mar 31, 2021-$13.20-$11.90-$21.80 - -$2.00-10.92%MissN/A4N/AMay 13, 2021
    Dec 31, 2020-$0.15N/AN/AN/AN/AN/AN/AN/AMar 22, 2021
    Last 23 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$10.18, after -$8.94 the year before. It was -$0.15 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$10.18N/A
    Dec 31, 2024-$8.94N/A
    Dec 31, 2023-$11.66N/A
    Dec 31, 2022-$26.44N/A
    Dec 31, 2021-$25.63N/A
    Dec 31, 2020-$0.15N/A

    Frequently Asked Questions About TIL

    When is Instil Bio's next earnings date?

    Instil Bio's next earnings report is expected for Mar 25, 2027.

    Did TIL beat earnings estimates last quarter?

    No. Instil Bio reported EPS of -$0.63 for the quarter ended Jun 30, 2026, below the -$0.35 estimate by 80.00%.

    What EPS do analysts expect from TIL next quarter?

    The consensus EPS estimate for Instil Bio for the quarter ending Dec 31, 2026 is -$0.04 from 2 analysts, with estimates from -$0.04 to -$0.04.

    How often does TIL beat earnings estimates?

    Instil Bio beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +0.81%.